Method Development, Validation and Transfer

Method Development, Validation and Transfer

Method validation is essential for compliance with current good manufacturing specifications (CGMP) and good laboratory specifications (GLP). Analytical method validation (AMV) is the requirement of the biopharmaceutical industry for all methods used in the testing of raw materials, in-process materials, final containers and excipients. The development and validation of analytical methods are critical to drug development and access to reliable analytical data that you need to reach your next development milestone. The development and validation of methods can be complex, expensive, and labor-intensive. A full understanding of current regulatory expectations and related chemical methods, coupled with advanced instrumentation, is essential for the development of efficient, accurate and reliable analytical methods.

BOC Sciences is pleased to offer Analytical Method Development, Validation and Transfer services:

Methodologies will be developed to assess the ability to measure compounds of interest in the final solution of interest in actual use. Specific analytical methods need to be developed and validated before any quantitative leachate assessment of drugs can be carried out. Although deviations, such as lower validation levels for some applications, are possible, MD&V (Method Development, Validation) is based on the ICHQ2 (R1) method validation guide. These tests may include parameter specificity, linearity, method range, accuracy, precision, LOD/LOQ, and robustness.

The generation of high-quality analytical data is imperative in the effective knowledge generation and development of new medicines. Analytical methods are the tools that generate data used to make fundamental development decisions, and validation demonstrates that methods are fit for this purpose. According to FDA, it is recommended that methods be developed and verified in each solution of interest. This allows for a more comprehensive assessment of potential matrix interference from the test matrix.

The transfer of an analytical method from an originally developed and validated laboratory to another laboratory, which is an important issue during the life cycle of a product, this process can only be provided by successful method transfers or by onsite validated methods, these methods are commonly used in the pharmaceutical industry.

Our Advantages

  • All our work strictly complies with cGMP requirements, and our analytical operations are based on formal written, detailed standard operating procedures and strict quality assurance measures.
  • Typical Analytical Characteristics Used: accuracy, precision, specificity, LOD/LOQ, linearity, range, and robustness.
  • By qualified personnel with adequate resources.
  • Handled by utilizing a protocol or plan agreed upon by both the client and BOC Sciences.
  • Communicate efficiently between BOC Sciences and customers.
  • Our standard reporting format includes a copy of the analytical method, a copy of the agreement, all test results, appropriate charts and calculations, and sample raw data.

BOC Sciences has the latest advanced analytical instruments and top experts in all analytical areas. We can provide drug detection, environmental analysis, explosives investigation and identification of unknown samples even it is a very small amount of a substance.


  1. Swartz, M. E., & Krull, I. S. (1997). Analytical method development and validation. CRC Press.
  2. Sahu, P. K., Ramisetti, N. R., Cecchi, T., Swain, S., Patro, C. S., & Panda, J. (2018). An overview of experimental designs in HPLC method development and validation. Journal of pharmaceutical and biomedical analysis, 147, 590-611.
Online Inquiry
Verification code